Product Recalls in Mississippi

Product recalls affecting Mississippi — including food, drugs, consumer products, medical devices, and vehicles distributed to Mississippi. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,661 recalls have been distributed to Mississippi in the last 12 months.

49,744 total recalls
2,661 in last 12 months

Showing 29612980 of 13,570 recalls

DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules USP Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 10 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 20 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 40 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL) Recalled by...

The Issue: CGMP Deviations: all products within expiry are being recalled because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Erythromycin Topical Gel USP Recalled by McKesson Corporation dba McKesson...

The Issue: CGMP Deviations: all products within expiry are being recalled because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Halobetasol Propionate Ointment 0.05% Net Wt. Recalled by McKesson...

The Issue: CGMP Deviations: all products within expiry are being recalled because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Lidocaine Prilocaine Cream USP Recalled by McKesson Corporation dba McKesson...

The Issue: CGMP Deviations: all products within expiry are being recalled because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Betamethasone Dipropionate Ointment USP Recalled by McKesson Corporation dba...

The Issue: CGMP Deviations: all products within expiry are being recalled because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets Recalled by Macleods Pharma Usa Inc Due to CGMP...

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets Recalled by Macleods Pharma Usa Inc Due to CGMP...

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets Recalled by Macleods Pharma Usa Inc Due to CGMP...

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium & Hydrochlorothiazide Tablets Recalled by Macleods Pharma...

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2022· Akorn, Inc.

Recalled Item: Lidocaine Hydrochloride Oral Topical Solution Recalled by Akorn, Inc. Due to...

The Issue: Failed viscosity specification - product was below specificcation

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium & Hydrochlorothiazide Tablets Recalled by Macleods Pharma...

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium & Hydrochlorothiazide Tablets Recalled by Macleods Pharma...

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2022· Teva Pharmaceuticals USA Inc

Recalled Item: Lidocaine 2.5% and Prilocaine 2.5% Cream Recalled by Teva Pharmaceuticals...

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 13, 2022· Mckesson Medical-Surgical Inc. Corporate Office

Recalled Item: Epinephrine Recalled by Mckesson Medical-Surgical Inc. Corporate Office Due...

The Issue: cGMP deviations: Temperature abuse

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 13, 2022· Mckesson Medical-Surgical Inc. Corporate Office

Recalled Item: Proventil HFA Recalled by Mckesson Medical-Surgical Inc. Corporate Office...

The Issue: cGMP deviations: Temperature abuse

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund